Recent Posts on This Topic | See All >
[Source: TGen] - Dr. Heather Cunliffe, a scientific Investigator at the Translational Genomic Research Institute (TGen), will join the board of directors of the Phoenix Affiliate of Susan G. Komen for the Cure.
Dr. Cunliffe, the Head of TGen’s Breast and Ovarian Cancer Research Unit, begins her initial one-year term today on the 15-member board of the local Komen for the Cure affiliate, one of 125 such affiliates worldwide.
For more information: TGen scientist named to Phoenix board of Komen for the Cure
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.